BioCentury | May 5, 2020
Finance

May 4 Quick Takes: Following Lyra’s success, Ayala readies for NASDAQ IPO; plus Medable and Hyloris

...Hyloris Pharmaceuticals SA raised EUR15 million ($16.4 million) in a funding round from Scorpiaux, Noshaq, Saffelberg Investments...
BioCentury | Feb 14, 2015
Company News

Intrexon acquires mucosal therapeutics play ActoGeniX

...The company raised EUR 49 million ($55.5 million) in three equity rounds from investors including Saffelberg Investments...
BioCentury | Apr 22, 2013
Financial News

ActoGeniX completes venture financing

...Business: Drug delivery Date completed: 4/18/13 Type: Venture financing Raised: €10.7 million ($14 million) Investors: Saffelberg Investments...
Items per page:
1 - 3 of 3
BioCentury | May 5, 2020
Finance

May 4 Quick Takes: Following Lyra’s success, Ayala readies for NASDAQ IPO; plus Medable and Hyloris

...Hyloris Pharmaceuticals SA raised EUR15 million ($16.4 million) in a funding round from Scorpiaux, Noshaq, Saffelberg Investments...
BioCentury | Feb 14, 2015
Company News

Intrexon acquires mucosal therapeutics play ActoGeniX

...The company raised EUR 49 million ($55.5 million) in three equity rounds from investors including Saffelberg Investments...
BioCentury | Apr 22, 2013
Financial News

ActoGeniX completes venture financing

...Business: Drug delivery Date completed: 4/18/13 Type: Venture financing Raised: €10.7 million ($14 million) Investors: Saffelberg Investments...
Items per page:
1 - 3 of 3